Mechanism of T cell regulation by microRNAs

Cancer Biology and Medicine

Volumn 10, Issue 3, 2013, Pages 131-137

  Liu, Juan ^a   Wu, Chang Ping ^a   Lu, Bin Feng ^b   Jiang, Jing Ting ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Gene expression; MicroRNA; T cell

Indexed keywords

MICRORNA; MICRORNA 122; MICRORNA 125B; MICRORNA 145; MICRORNA 155; MICRORNA 182; MICRORNA 210; MICRORNA 214; MICRORNA 222; MICRORNA 24; MICRORNA 29; T LYMPHOCYTE RECEPTOR;

3' UNTRANSLATED REGION; APOPTOSIS; CANCER GROWTH; CANCER THERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL MATURATION; CELL SURVIVAL; CELLULAR IMMUNITY; GENE EXPRESSION; GENE REPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TUMOR CELL; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT;

EID: 84891283847     PISSN: 20953941     EISSN: None     Source Type: Journal    
DOI: 10.7497/j.issn.2095-3941.2013.03.002     Document Type: Review

References (57)

1. Lopez-Camarillo C, Marchat LA, Arechaga-Ocampo E, Perez-Plasencia C, Del Moral-Hernandez O, Castaneda-Ortiz E J, et al. MetastamiRs: Non-Coding MicroRNAs Driving Cancer Invasion and Metastasis. Int J Mol Sci 2012;13:1347-1379.
2. Dunn G P, Bruce A T, Ikeda H, Old L J, Schreiber R D. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 2002;3:991-998.
3. Zhang H G, Zhuang X, Sun D, Liu Y, Xiang X, Grizzle W E. Exosomes and immune surveillance of neoplastic lesions: a review. Biotech Histochem 2012;87:161-168.
4. Okada H, Kohanbash G, Lotze M T. MicroRNAs in immune regulation--opportunities for cancer immunotherapy. Int J Biochem Cell Biol 2010;42:1256-1261.
5. Holmstrøm K, Pedersen A W, Claesson M H, Zocca M B, Jensen S S. Identification of a microRNA signature in dendritic cell vaccines for cancer immunotherapy. Hum Immunol 2010;71:67-73.
6. Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O, et al. Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 2005;37:766-770.
7. Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk R H, Cuppen E. Phylogenetic shadowing and computational identification of human microRNA genes. Cell 2005;120:21-24.
8. Wu H, Neilson J R, Kumar P, Manocha M, Shankar P, Sharp P A, et al. miRNA profiling of naive, effector and memory CD8 T cells. PLoS One 2007;2:e1020.
9. Bushati N, Cohen S M. microRNA functions. Annu Rev Cell Dev Biol 2007;23:175-205.
10. Xiao C, Rajewsky K. MicroRNA control in the immune system: basic principles. Cell 2009;136:26-36.
11. Bartel D P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
12. Banerjee D, Kwok A, Lin S Y, Slack F J. Developmental timing in C. elegans is regulated by kin-20 and tim-1, homologs of core circadian clock genes. Dev Cell 2005;8:287-295.
13. Starr T K, Jameson S C, Hogquist K A. Positive and negative selection of T cells. Annu Rev Immunol 2003;21:139-176.
14. Salaun B, Yamamoto T, Badran B, Tsunetsugu-Yokota Y, Roux A, Baitsch L, et al. Differentiation associated regulation of microRNA expression in vivo in human CD8+ T cell subsets. J Transl Med 2011;9:44.
15. Romero P, Zippelius A, Kurth I, Pittet M J, Touvrey C, Iancu E M, et al. Four functionally distinct populations of human effectormemory CD8+ T lymphocytes. J Immunol 2007;178:4112-4119.
16. Harrington L E, Hatton R D, Mangan P R, Turner H, Murphy T L, Murphy K M, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005;6:1123-1132.
17. Baumjohann D, Ansel K M. MicroRNA-mediated regulation of T helper cell differentiation and plasticity. Nat Rev Immunol 2013;13:666-678.
18. Jindra P T, Bagley J, Godwin J G, Iacomini J. Costimulationdependent expression of microRNA-214 increases the ability of T cells to proliferate by targeting Pten. J Immunol 2010;185:990-997.
19. Neilson J R, Zheng G X, Burge C B, Sharp P A. Dynamic regulation of miRNA expression in ordered stages of cellular development. Genes Dev 2007;21:578-589.
20. Bi Y, Liu G, Yang R. MicroRNAs: novel regulators during the immune response. J Cell Physiol 2009;218:467-472.
21. Ooi A G, Sahoo D, Adorno M, Wang Y, Weissman I L, Park C Y. MicroRNA-125b expands hematopoietic stem cells and enriches for the lymphoid-balanced and lymphoid-biased subsets. Proc Natl Acad Sci U S A 2010;107:21505-21510.
22. Liu G, Min H, Yue S, Chen C Z. Pre-miRNA loop nucleotides control the distinct activities of mir-181a-1 and mir-181c in early T cell development. PLoS One 2008;3:e3592.
23. Muljo S A, Ansel K M, Kanellopoulou C, Livingston D M, Rao A, Rajewsky K. Aberrant T cell differentiation in the absence of Dicer. J Exp Med 2005;202:261-269.
24. Cobb B S, Hertweck A, Smith J, O'Connor E, Graf D, Cook T, et al. A role for Dicer in immune regulation. J Exp Med 2006;203:2519-2527.
25. Li Q J, Chau J, Ebert P J, Sylvester G, Min H, Liu G, et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 2007;129:147-161.
26. Fragoso R, Mao T, Wang S, Schaffert S, Gong X, Yue S, et al. Modulating the strength and threshold of NOTCH oncogenic signals by mir-181a-1/b-1. PLoS Genet 2012;8:e1002855.
27. Ghisi M, Corradin A, Basso K, Frasson C, Serafin V, Mukherjee S, et al. Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150. Blood 2011;117:7053-7062.
28. Zhang N, Bevan M J. Dicer controls CD8+ T-cell activation, migration, and survival. Proc Natl Acad Sci U S A 2010;107:21629-21634.
29. Grigoryev Y A, Kurian S M, Hart T, Nakorchevsky A A, Chen C, Campbell D, et al. MicroRNA regulation of molecular networks mapped by global microRNA, mRNA, and protein expression in activated T lymphocytes. J Immunol 2011;187:2233-2243.
30. Stittrich A B, Haftmann C, Sgouroudis E, Kuhl A A, Hegazy A N, Panse I, et al. The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes. Nat Immunol 2010;11:1057-1062.
31. Smigielska-Czepiel K, van den Berg A, Jellema P, Slezak-Prochazka I, Maat H, van den Bos H, et al. Dual Role of miR-21 in CD4+T-Cells: Activation-Induced miR-21 Supports Survival of Memory T-Cells and Regulates CCR7 Expression in Naive T-Cells. PLoS One 2013;8:e76217.
32. O'Donnell K A, Wentzel E A, Zeller K I, Dang C V, Mendell J T. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005;435:839-843.
33. Jiang S, Li C, Olive V, Lykken E, Feng F, Sevilla J, et al. Molecular dissection of the miR-17-92 cluster's critical dual roles in promoting Th1 responses and preventing inducible Treg differentiation. Blood 2011;118:5487-5497.
34. Lykken E A, Li Q J. microRNAs at the regulatory frontier: an investigation into how microRNAs impact the development and effector functions of CD4 T cells. Immunol Res 2011;49:87-96.
35. Wu T, Wieland A, Araki K, Davis C W, Ye L, Hale J S, et al. Temporal expression of microRNA cluster miR-17-92 regulates effector and memory CD8+ T-cell differentiation. Proc Natl Acad Sci U S A 2012;109:9965-9970.
36. Xiao C, Srinivasan L, Calado D P, Patterson H C, Zhang B, Wang J, et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 2008;9:405-414.
37. Trifari S, Pipkin M E, Bandukwala H S, Aij T, Bassein J, Chen R, et al. MicroRNA-directed program of cytotoxic CD8+ T-cell differentiation. Proc Natl Acad Sci U S A 2013;110:18608-18613.
38. Lorenzi J C, Brum D G, Zanette D L, de Paula Alves Souza A, Barbuzano F G, Dos Santos A C, et al. miR-15a and 16-1 Are Downregulated in CD4(+) T Cells of Multiple Sclerosis Relapsing Patients. Int J Neurosci 2012;122:466-71.
39. Marrack P, Kappler J. Control of T cell viability. Annu Rev Immunol 2004;22:765-787.
40. Molitoris J K, McColl K S, Distelhorst C W. Glucocorticoidmediated repression of the oncogenic microRNA cluster miR-17~92 contributes to the induction of Bim and initiation of apoptosis. Mol Endocrinol 2011;25:409-420.
41. Manfè V, Biskup E, Rosbjerg A, Kamstrup M, Skov A G, Lerche C M, et al. miR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma. PLoS One 2012;7:e29541.
42. Almanza G, Fernandez A, Volinia S, Cortez-Gonzalez X, Croce C M, Zanetti M. Selected microRNAs define cell fate determination of murine central memory CD8 T cells. PLoS One 2010;5:e11243.
43. Zhou Q, Haupt S, Prots I, Thümmler K, Kremmer E, Lipsky PE, et al. miR-142-3p is involved in CD25+ CD4 T cell proliferation by targeting the expression of glycoprotein A repetitions predominant. J Immunol 2013;190:6579-6588.
44. Lu T X, Hartner J, Lim E J, Fabry V, Mingler M K, Cole E T, et al. MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-gamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity. J Immunol 2011;187:3362-3373.
45. Ma F, Xu S, Liu X, Zhang Q, Xu X, Liu M, et al. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-gamma. Nat Immunol 2011;12:861-869.
46. Steiner D F, Thomas M F, Hu J K, Yang Z, Babiarz J E, Allen C D, et al. MicroRNA-29 regulates T-box transcription factors and interferongamma production in helper T cells. Immunity 2011;35:169-181.
47. Li Z, Wu F, Brant S R, Kwon J H. IL-23 receptor regulation by Let-7f in human CD4+ memory T cells. J Immunol 2011;186:6182-6190.
48. Rossi R L, Rossetti G, Wenandy L, Curti S, Ripamonti A, Bonnal R J, et al. Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b. Nat Immunol 2011;12:796-803.
49. Fayyad-Kazan H, Rouas R, Fayyad-Kazan M, Badran R, El Zein N, Lewalle P, et al. MicroRNA profile of circulating CD4-positive regulatory T cells in human adults and impact of differentially expressed microRNAs on expression of two genes essential to their function. J Biol Chem 2012;287:9910-9922.
50. Takahashi H, Kanno T, Nakayamada S, Hirahara K, Sciume G, Muljo S A, et al. TGF-β and retinoic acid induce the microRNA miR-10a, which targets Bcl-6 and constrains the plasticity of helper T cells. Nat Immunol 2012;13:587-595.
51. Yamamoto M, Kondo E, Takeuchi M, Harashima A, Otani T, Tsuji-Takayama K, et al. miR-155, a Modulator of FOXO3a Protein Expression, Is Underexpressed and Cannot Be Upregulated by Stimulation of HOZOT, a Line of Multifunctional Treg. PLoS One 2011;6:e16841.
52. Lu L F, Boldin M P, Chaudhry A, Lin L L, Taganov K D, Hanada T, et al. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 2010;142:914-929.
53. Sasaki K, Kohanbash G, Hoji A, Ueda R, McDonald H A,Reinhart T A, et al. miR-17-92 expression in differentiated T cells-implications for cancer immunotherapy. J Transl Med 2010;8:17.
54. Ueda R, Kohanbash G, Sasaki K, Fujita M, Zhu X, Kastenhuber E R, et al. Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by downregulation of ICAM-1. Proc Natl Acad Sci U S A 2009;106:10746-10751.
55. Gong A Y, Zhou R, Hu G, Liu J, Sosnowska D, Drescher K M, et al. Cryptosporidium parvum induces B7-H1 expression in cholangiocytes by down-regulating microRNA-513. J Infect Dis 2010;201:160-169.
56. Xu H, Cheung I Y, Guo H F, Cheung N K. MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors. Cancer Res 2009;69:6275-6281.
57. Gao Y, He Y, Ding J, Wu K, Hu B, Liu Y, et al. An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3' untranslated region confers risk for hepatocellular carcinoma. Carcinogenesis 2009;30:2064-2069.